![](/cdn.cnn.com/cnn/.e1mo/img/4.0/logos/menu_health.png)
biohaven: "rimegepant pivotal phase 3 trial results -- conference call." .
sources
.
.
.
.: "arise: a phase 3 randomized trial of erenumab for episodic migraine."
.
. share on pinterest pinterest
.
.
$17
OFF DEAL
GET DEAL
218 Used Today
50%
OFF DEAL
OFF DEAL
218 Used Today
OFF DEAL